Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

N-glycosylation blockers reduce SARS-CoV-2 infection

N-glycosylation blockers reduce SARS-CoV-2 infection

Inhalable antibody fragments offer broad protection from SARS-CoV-2 variants

Inhalable antibody fragments offer broad protection from SARS-CoV-2 variants

Mechanism of fatty-acid coupled adaptive immunity in SARS-CoV-2 revealed

Mechanism of fatty-acid coupled adaptive immunity in SARS-CoV-2 revealed

Researchers develop novel anti-SARS-CoV-2 Omicron vaccine candidate

Researchers develop novel anti-SARS-CoV-2 Omicron vaccine candidate

Four times as many children hospitalized during Omicron COVID wave compared to Delta

Four times as many children hospitalized during Omicron COVID wave compared to Delta

The impact of SARS-CoV-2 on lipids

The impact of SARS-CoV-2 on lipids

T-cell responses linked with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer

T-cell responses linked with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer

Inmates who died asked for release before falling ill with covid

Inmates who died asked for release before falling ill with covid

Omicron outbreak in an indoor convention in New York

Omicron outbreak in an indoor convention in New York

Study characterizes COVID-19 vaccine effectiveness at longer dose intervals

Study characterizes COVID-19 vaccine effectiveness at longer dose intervals

Research provides a stronger connection between autoantibody formation and clotting in COVID-19

Research provides a stronger connection between autoantibody formation and clotting in COVID-19

Study reports a highly attenuated SARS-CoV-2 that could serve as a live-attenuated vaccine platform

Study reports a highly attenuated SARS-CoV-2 that could serve as a live-attenuated vaccine platform

Study reveals the structural, functional landscape of neutralizing antibodies against SARS-CoV-2 spike protein

Study reveals the structural, functional landscape of neutralizing antibodies against SARS-CoV-2 spike protein

SARS-CoV-2 Mpro inhibitor, nirmatrelvir, found to reduce COVID-19 progression and death

SARS-CoV-2 Mpro inhibitor, nirmatrelvir, found to reduce COVID-19 progression and death

VA researchers shine light on the dangerous mental health consequences of COVID-19

VA researchers shine light on the dangerous mental health consequences of COVID-19

The ability of therapeutic monoclonal antibodies to neutralize SARS-CoV-2 Omicron BA.2 variant

The ability of therapeutic monoclonal antibodies to neutralize SARS-CoV-2 Omicron BA.2 variant

Demonstrating effectiveness of BNT162b2 vaccine in preventing reinfections after COVID-19 recovery

Demonstrating effectiveness of BNT162b2 vaccine in preventing reinfections after COVID-19 recovery

Meta-analysis of population-based seroprevalence studies to estimate SARS-CoV-2 seroprevalence in Africa

Meta-analysis of population-based seroprevalence studies to estimate SARS-CoV-2 seroprevalence in Africa

Response of peripheral immune cells to ex vivo SARS-CoV-2 exposure compared to SARS-CoV

Response of peripheral immune cells to ex vivo SARS-CoV-2 exposure compared to SARS-CoV

Study explores efficacy of mRNA vaccine booster doses during the SARS-CoV-2 Omicron wave

Study explores efficacy of mRNA vaccine booster doses during the SARS-CoV-2 Omicron wave

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.